By Krista Conger
A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway — a series of interactions among proteins — involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.
The findings were published online Sept. 15 in two articles in Nature Medicine.
To read the full story visit: http://med.stanford.edu/ism/2013/september/diabetes.html#sthash.IuKOEWbM.dpuf
